Answers are grounded in this paper and cite their sources.
The cholera toxin B subunit (CTB), traditionally regarded as a non-toxic immunomodulator, has recently been implicated in epigenetic regulation; however, its role in periodontitis remains unclear. Here, we identify exogenous CTB aggravates experimental periodontal inflammation. In a murine model of periodontitis, CTB markedly exacerbated alveolar bone loss, suggesting its pathogenic relevance in vivo. Mechanistically, integrated transcriptomic, proteomic, lactylomic, and experimental analyses suggested that CTB-associated inflammatory responses involve metabolic remodeling and enhanced Serpinb3 K63-linked lactylation in macrophages. Functional studies using Serpinb3-deficient macrophages and mice further demonstrated that Serpinb3 contributes to CTB-induced inflammatory activation and periodontal bone loss. These findings identify an experimental role of CTB in potentiating periodontal inflammation and bone destruction and suggest that increased Serpinb3 K63-lactylation is associated with CTB-induced macrophage reprogramming. However, the site-specific functional requirement of Serpinb3 K63-lactylation remains to be determined. This work provides mechanistic insight into host–toxin interactions and identifies a potential immunometabolic regulatory axis that warrants further investigation in inflammatory bone loss.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: